Severe and Fatal Influenza Cases in Russia in 2014-2015

Svyatchenko, Svetlana V.; Durymanov, A. G.; Susloparov, Ivan M.; Kolosova, Natalia; Гончарова, Н. И.; Михеев, В. Н.; Ryzhikov, Alexander B.; Ilyicheva, T. N.

doi:10.3844/ojbsci.2016.184.192

Cited by 2 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Virus agglutination of guinea pig erythrocytes was registered after two or more passages in MDCK cell culture. After hemagglutination registration, we subtyped strains in HI tests with reference sera to A/ Switzerland/9715293/2013 and A/HongKong/4801/2014 viruses and diagnostic ferret sera against A/Nizhniy Novgorod/8713/2014 virus that we isolated in November 2014 [11]. HI tests were carried out in the presence of oseltamivir (20 nM) (Table 4).…”

Section: Characterization Of Influenza Viruses Isolated From Autopsy and Clinical Materialsmentioning

confidence: 99%

Humoral immunity to influenza in an at-risk population and severe influenza cases in Russia in 2016–2017

et al. 2018

Self Cite

View full text Add to dashboard Cite

This work aimed to analyze the herd immunity to influenza among a Russian population living in regions with an increased risk of emergence of viruses with pandemic potential, and to isolate and investigate virus strains from severe influenza cases, including fatal cases, during the 2016-2017 epidemic season. In November 2016 - March 2017 highly pathogenic influenza outbreaks were registered in Russia among wild birds and poultry. No cases of human infection were registered. Analysis of 760 sera from people who had contact with infected or perished birds revealed the presence of antibodies to A(H5N1) virus of clade 2.3.2.1c and A(H5N8) virus of clade 2.3.4.4. The 2016-2017 influenza epidemic season in Russia began in weeks 46-47 of 2016 with predominant circulation of influenza A(H3N2) viruses. Strains isolated from severe influenza cases mainly belonged to 3C.2a.2 and 3C.2a.3 genetic groups. Up to the 8th week of 2017 severe influenza cases were often caused by influenza B viruses which belonged to 1A genetic group with antigenic properties similar to B/Brisbane/60/2008. All influenza A and B virus strains isolated in the 2016-2017 epidemic season were sensitive to oseltamivir and zanamivir.

show abstract

Section: Characterization Of Influenza Viruses Isolated From Autopsy and Clinical Materialsmentioning

confidence: 99%

Humoral immunity to influenza in an at-risk population and severe influenza cases in Russia in 2016–2017

et al. 2018

Self Cite

View full text Add to dashboard Cite

show abstract

“…We also analyzed correlation between the studies devoted to vaccine construction and other studies on influenza such as influenza epidemiology including molecular epidemiology, antiviral therapy, development of new antiviral drugs to prevent future pandemics (Ilyicheva et al, 2016;2013;2011;Svyatchenko et al, 2016). For the purpose, we analyzed overall amount of papers on influenza ( Fig.…”

Section: Scholarly Output On Influenza Vaccinesmentioning

confidence: 99%

An Informetric Analysis of Studies on Influenza Vaccines and Vaccination

Гуреев¹,

Мазов²,

Ilyicheva³

et al. 2017

OnLine Journal of Biological Sciences

View full text Add to dashboard Cite

Influenza is one of highly contagious acute virus diseases that primarily affects respiratory ways. Annual seasonal epidemics afflict approximately 15% population worldwide and lead to 250,000-500,000 deaths each year. That is why studies on influenza vaccines and vaccination that prevent spreading of the virus remain highly important. This paper presents the results of informetric analysis of publications on influenza vaccine development and vaccination against influenza based on Web of Science databases. The authors analyzed scholarly output from 2001 to 2015. We detected annual increase in the number of publications since 2002, but the highest interest to influenza vaccination was observed in 2009-2011 years due to emergence of new H1N1 virus. After 2011 we registered decrease in publication activity although this subject area is still in the focus of researchers. Journal original papers and reviews seem to be the main source of information, while a share of conference papers consistently decreased over the analyzed period. United States is a leader in the number of research with 40% of all papers which account for 55% of all citations. Elsevier's Vaccine is a primary journal publishing nearly 20% of papers; however, results of influenza vaccine development have also been published in extremely authoritative journals including The New England Journal of Medicine, Lancet, Science, British Medical Journal, Nature Medicine, etc. This also highlights the great importance of studies on the analyzed topic. Thus, the paper represents different aspects and trends in influenza vaccine development in the last 15 years using a broad range of bibliometric approaches including citation analysis, collaboration networks, revealing the most active countries studying influenza vaccine development, the most authoritative journals and funding organizations.

show abstract

Severe and Fatal Influenza Cases in Russia in 2014-2015

Cited by 2 publications

References 10 publications

Humoral immunity to influenza in an at-risk population and severe influenza cases in Russia in 2016–2017

Humoral immunity to influenza in an at-risk population and severe influenza cases in Russia in 2016–2017

An Informetric Analysis of Studies on Influenza Vaccines and Vaccination

Contact Info

Product

Resources

About